Circulating Tumor Cells Market (CTCs) and Cancer Stem Cells Market (CSCs) Will Reach USD 7.9 billion by 2018 : Transparency Market Research

Share Article

Transparency Market Research Published new "Circulating Tumor Cells Market (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018" market research report to its report store. Browse the report; visit http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html

Transparency Market Research

Transparency Market Research

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

According to Transparency Market Research “Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market – Global Scenario, Trends, Size, Growth and Industry Analysis, 2011 – 2018.” CTCs and CSCs Market is estimated to reach USD 7.9 billion by 2018.

The study shows that in the overall CTCs and CSCs global market, the U.S. is expected to maintain its lead position in terms of revenue till 2018. The global market for cancer diagnostics based on Circulating Cancer Cells (CTCs) was estimated at USD 1.0 billion in 2011.

Related Report : Biotechnology Market
http://www.transparencymarketresearch.com/biotechnology-market.html

The rising prevalence of diseases like cancer and the reimbursement support by regulatory bodies in developed countries like United States and Europe are the major factors driving the growth of the CTCs and CSCs market. Though the currently used detection method lacks sensitivity or specificity to track all CTCs particularly the ones that have lost characteristic epithelial features, there is still good scope for pharmaceutical companies in the CTCs and CSCs field. The various sub-types of cancer may have their own classes and it creates an opportunity in the future.

Increase in cancer mortality rate in the past few years and an increase in number of cancer patients offers an opportunity for pharmaceutical companies to enter this sector. Every one person out of eight has the potential of getting affected by cancer and it is estimated that 12 to 37 lives can be saved daily with the help of CTCs and CSCs.

Related Report : Peptide Therapeutics Market
http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The major geographic markets for CTCs and CSCs are the U.S. and Europe. The U.S. accounted for more than 50% of the worldwide CTCs and CSC market in 2011.

This research is specially designed to estimate and analyze the demand and performance of CTCs and CSC products in a global scenario. The report covers all the major segments of the global CTC and CSC market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global CTC and CSC market.

Browse Bolg : Pharmaceutical Market Research Reports
http://pharmaceutical-market-reports.blogspot.com/

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood. CTC technology offers advantages like high sensitivity, high specificity, reproducible, repeatable, and non-invasive diagnostic assay for guiding treatment decision and improved patient triage. Circulatory tumor cells (CTC) are cancer cells that get separated from the primary tumor or its metastases that circulate in the peripheral blood. Metastasis the major cause of cancer deaths and CTC may constitute seeds from metastases and indicate the spread of diseases.

Browse Bolg : Market consultants
http://marketconsultants.blogspot.com/

The circulating tumor cells' analysis will allow early detection of metastasis when it is less invasive. Molecular characterization of CTC enables the treatment to be planned effectively. Removing CTC from the blood will limit metastases after surgery or therapy. Molecular characterization is significant from the point of view of developing new methodologies for CTC detection, isolation, enumeration, and subsequent genetic or proteomic analysis.

Browse the full report with TOC at http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html

Advancement in medical technologies is allowing efficient removal of CTC from circulation and has therapeutic potential. This research report analyzes the Circulating tumor cells and cancer stem cells market from a technical as well as business perspective, describing the overall market size, industry growth rate, and market trends. It gives an analysis of the recent developments in CTC and CSC markets and includes detailed profiles of top industry players along with Porter’s five force analysis. The report also analyzes all the micro and macro factors essential for the existing market players and new entrants.

Browse All Market Research Reports: http://www.transparencymarketresearch.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sheela AK
Follow us on
Visit website